Genetic Implications for Cancer Management: The Changing Landscape of Poly (ADP-ribose) Polymerase Inhibitor Indications in the Treatment of Ovarian Cancer.

MLA

Walsh, Christine. “Genetic Implications for Cancer Management: The Changing Landscape of Poly (ADP-Ribose) Polymerase Inhibitor Indications in the Treatment of Ovarian Cancer.” Clinical Obstetrics and Gynecology, vol. 67, no. 4, Dec. 2024, pp. 711–19. EBSCOhost, https://doi.org/10.1097/GRF.0000000000000896.

APA

Walsh, C. (2024). Genetic Implications for Cancer Management: The Changing Landscape of Poly (ADP-ribose) Polymerase Inhibitor Indications in the Treatment of Ovarian Cancer. Clinical Obstetrics and Gynecology, 67(4), 711–719. https://doi.org/10.1097/GRF.0000000000000896

Chicago

Walsh, Christine. 2024. “Genetic Implications for Cancer Management: The Changing Landscape of Poly (ADP-Ribose) Polymerase Inhibitor Indications in the Treatment of Ovarian Cancer.” Clinical Obstetrics and Gynecology 67 (4): 711–19. doi:10.1097/GRF.0000000000000896.